Genitourinary Cancer
  • Featured content
    David R. Gandara, MD; Daniel M. Geynisman, MD; Sara Hurvitz, MD, FACP; Elias Jabbour, MD; Shaji Kumar, MD; Brian Rini, MD, FACP; Tiffany A. Traina, MD; and Heather A. Wakelee, MD, each provide an analysis of key presentations on cancer immunotherapy from the 2016 clinical oncology meeting in Chicago.
  • Featured content
    David R. Gandara, MD; Daniel M. Geynisman, MD; Sara Hurvitz, MD, FACP; Elias Jabbour, MD; Shaji Kumar, MD; Brian Rini, MD, FACP; Tiffany A. Traina, MD; and Heather A. Wakelee, MD, provide an analysis of key presentations on cancer immunotherapy from the 2016 Clinical Oncology meeting in Chicago.
    Date Posted: 9/19/2016
  • Featured content
    In this activity, Daniel M. Geynisman, MD, and Brian Rini, MD, FACP, analyze and discuss the most clinically relevant data on the management of genitourinary cancers presented at the 2016 ASCO annual meeting.
  • Featured content
    In this downloadable slideset, Daniel P. Petrylak, MD, reviews key data and important changes to clinical practice in the management of advanced and metastatic urothelial carcinoma, including data presented at the 2016 American Society of Clinical Oncology Meeting.
    Date Posted: 7/6/2016
  • Featured content
    Daniel P. Petrylak, MD, reviews current research on immunotherapies and provides his perspective on optimal management strategies for patients with bladder cancer.
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 115 Shown
10 of 115 Shown
Show 10 More
Loading...